PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,044,154 | -58.2% | 180,462 | -24.1% | 0.00% | -100.0% |
| Q2 2023 | $9,675,636 | +38.0% | 237,906 | +64.4% | 0.00% | +100.0% |
| Q1 2023 | $7,011,641 | +18.2% | 144,749 | -6.9% | 0.00% | -50.0% |
| Q4 2022 | $5,934,481 | -37.6% | 155,475 | -17.9% | 0.00% | -33.3% |
| Q3 2022 | $9,504,000 | +265.0% | 189,306 | +191.3% | 0.00% | +200.0% |
| Q2 2022 | $2,604,000 | -37.0% | 64,997 | -41.3% | 0.00% | – |
| Q1 2022 | $4,131,000 | -39.6% | 110,750 | -35.5% | 0.00% | – |
| Q4 2021 | $6,836,000 | -0.2% | 171,650 | -6.8% | 0.00% | – |
| Q3 2021 | $6,849,000 | +67.5% | 184,089 | +90.3% | 0.00% | – |
| Q2 2021 | $4,089,000 | -48.2% | 96,748 | -42.0% | 0.00% | -100.0% |
| Q1 2021 | $7,900,000 | -2.4% | 166,863 | +25.8% | 0.00% | 0.0% |
| Q4 2020 | $8,096,000 | -4.2% | 132,658 | -26.7% | 0.00% | 0.0% |
| Q3 2020 | $8,454,000 | -33.2% | 180,866 | -27.5% | 0.00% | -66.7% |
| Q2 2020 | $12,661,000 | -10.6% | 249,524 | -21.4% | 0.00% | -40.0% |
| Q1 2020 | $14,164,000 | -45.3% | 317,495 | -41.1% | 0.01% | -37.5% |
| Q4 2019 | $25,907,000 | +26.0% | 539,400 | -11.3% | 0.01% | +14.3% |
| Q3 2019 | $20,561,000 | -30.2% | 607,931 | -7.1% | 0.01% | +75.0% |
| Q2 2019 | $29,463,000 | +369.6% | 654,712 | +292.7% | 0.00% | +100.0% |
| Q1 2019 | $6,274,000 | -26.2% | 166,700 | -32.7% | 0.00% | -50.0% |
| Q4 2018 | $8,505,000 | -44.9% | 247,800 | -24.6% | 0.00% | -20.0% |
| Q3 2018 | $15,444,000 | +15.1% | 328,600 | -17.4% | 0.01% | +25.0% |
| Q2 2018 | $13,415,000 | +4.5% | 397,710 | -16.2% | 0.00% | -20.0% |
| Q1 2018 | $12,837,000 | -27.2% | 474,400 | -55.1% | 0.01% | -28.6% |
| Q4 2017 | $17,637,000 | -57.4% | 1,057,351 | -48.8% | 0.01% | -56.2% |
| Q3 2017 | $41,358,000 | +348.1% | 2,066,870 | +310.5% | 0.02% | +220.0% |
| Q2 2017 | $9,229,000 | +82.9% | 503,530 | -1.8% | 0.01% | +150.0% |
| Q1 2017 | $5,045,000 | -51.3% | 512,700 | -46.0% | 0.00% | -60.0% |
| Q4 2016 | $10,349,000 | +89.6% | 948,649 | +143.5% | 0.01% | +150.0% |
| Q3 2016 | $5,458,000 | +81.9% | 389,600 | -8.8% | 0.00% | 0.0% |
| Q2 2016 | $3,000,000 | -11.4% | 427,388 | -18.7% | 0.00% | 0.0% |
| Q1 2016 | $3,386,000 | -83.2% | 525,721 | -15.4% | 0.00% | -77.8% |
| Q4 2015 | $20,130,000 | -16.9% | 621,300 | -31.5% | 0.01% | -18.2% |
| Q3 2015 | $24,213,000 | -15.6% | 906,840 | +52.1% | 0.01% | -8.3% |
| Q2 2015 | $28,690,000 | -16.3% | 596,116 | +5.8% | 0.01% | -25.0% |
| Q1 2015 | $34,294,000 | +1181.5% | 563,570 | +990.5% | 0.02% | +1500.0% |
| Q4 2014 | $2,676,000 | +859.1% | 51,681 | +384.5% | 0.00% | – |
| Q2 2014 | $279,000 | +9.4% | 10,666 | +9.3% | 0.00% | – |
| Q1 2014 | $255,000 | – | 9,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |